In our hands, targeting of DLC1-v1 with specific shRNA in KT21cells established from human malignant meningioma resulted in enhanced activity of RhoA/RhoB/RhoC GTPases as shown in active RHO pull down assay and increased cell migration in scratch assay. This evidence concerns the gene RHOC and Anaplastic (Malignant) Meningioma.